Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 21, 2020 Filed Oct 16, 2020 21:00 UTC |
Marshman Fund Trust II10% owner
|
PurchaseCommon Stock | 339,476 | $24.00 | $8,147,424.00 |
DisclosureSEC source: 0000899243-20-028512 · doc4.xml · nonDerivative · entry 1 Marshman Fund Trust II · CIK 0001821461 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,651,120 F1 · balance_after: On September 4, 2020, the reporting person filed a Form 4 amendment that incorrectly stated the number of shares of common stock beneficially owned after the reported transaction. Following the transactions reported hereing, as of August 21, 2020, the reporting person owned 10,651,120 shares of Common Stock. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 21:09 UTC |
Nielsen JackDirector
|
PurchaseCommon Stock | 2,736 | $35.00 | $95,760.00 |
DisclosureSEC source: 0000899243-20-023341 · doc4.xml · nonDerivative · entry 1 Nielsen Jack · CIK 0001602402 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,736 F1 · ownership.nature: The shares are held of record by Vivo Capital Fund IX, L.P. Vivo Capital IX, LLC is the General Partner of Vivo Capital Fund IX, L.P. As a managing member of Vivo Capital IX, LLC, Jack Nielsen shares voting and dispositive power with respect to the shares held of record by Vivo Capital Fund IX, L.P with other managing members, but disclaims beneficial ownership of such shares except to the extent of his individual pecuniary interest therein. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 20:00 UTC |
ARONIN JEFFREY SDirector
|
GrantStock Option · Derivative | 1,259,611 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023122 · doc4.xml · derivative · entry 1 ARONIN JEFFREY S · CIK 0001062364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,259,611 Underlying: Common Stock · 1,259,611 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in five equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 21, 2020 00:06 UTC |
Gracias Antonio J.Director
|
GrantStock Option · Derivative | 12,617 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023133 · doc4.xml · derivative · entry 1 Gracias Antonio J. · CIK 0001495158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,617 Underlying: Common Stock · 12,617 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 20:03 UTC |
Nielsen JackDirector
|
GrantStock Option · Derivative | 9,012 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023127 · doc4.xml · derivative · entry 1 Nielsen Jack · CIK 0001602402 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012 Underlying: Common Stock · 9,012 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 20:08 UTC |
Dayno Jeffrey M.Chief Medical Officer
|
GrantStock Option · Derivative | 132,260 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023135 · doc4.xml · derivative · entry 1 Dayno Jeffrey M. · CIK 0001615993 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,260 Underlying: Common Stock · 132,260 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in five equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 23:59 UTC |
Sender GaryDirector
|
GrantStock Option · Derivative | 16,583 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023121 · doc4.xml · derivative · entry 1 Sender Gary · CIK 0001659085 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,583 Underlying: Common Stock · 16,583 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 21, 2020 00:13 UTC |
Jacobs John CDirector · President, CEO
|
GrantStock Option · Derivative | 144,856 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023136 · doc4.xml · derivative · entry 1 Jacobs John C · CIK 0001820836 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,856 Underlying: Common Stock · 144,856 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in five equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 21, 2020 00:05 UTC |
Serafin AndrewChief Business Officer
|
GrantStock Option · Derivative | 81,875 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023130 · doc4.xml · derivative · entry 1 Serafin Andrew · CIK 0001821460 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,875 Underlying: Common Stock · 81,875 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in five equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 21, 2020 00:05 UTC |
Dierks JeffreyChief Commercial Officer
|
GrantStock Option · Derivative | 144,856 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023131 · doc4.xml · derivative · entry 1 Dierks Jeffrey · CIK 0001821102 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,856 Underlying: Common Stock · 144,856 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in five equal annual installments beginning on August 21, 2021. Read SEC document |
| August 18, 2020 Filed Aug 21, 2020 00:02 UTC |
Sabater Juan A.Director
|
GrantStock Option · Derivative | 9,012 | $0.00 Strike: $24.00 | $0.00 |
DisclosureSEC source: 0000899243-20-023125 · doc4.xml · derivative · entry 1 Sabater Juan A. · CIK 0001821210 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,012 Underlying: Common Stock · 9,012 shares Expires 2030-08-18 F1 · derivative.exercise_date: The stock option shall vest in three equal annual installments beginning on August 21, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.